Clinical immunologist Dr Mina John discusses why considerations of long-term safety associated with antiretroviral therapy are important in HIV management and care.
Clinical immunologist Dr Mina John discusses why considerations of long-term safety associated with antiretroviral therapy are important in HIV management and care.
Dr Mina John discusses the data behind why considerations of long-term safety associated with antiretroviral therapy are important in HIV management and care.
Meet Dr Mina John, clinical immunologist and immunopathologist at Royal Perth Hospital, Western Australia.
Chapter 2_
What The Data Tells Us
Dr Mina John discusses the data behind why considerations of long-term safety associated with antiretroviral therapy are important in HIV management and care.
Chapter 3_
Translating Data Into Practice
A case study exploring how this data translates into practice.
Chapter 4_
Final Thoughts
Where to from here? In this closing chapter Dr John shares her hopes for the future of HIV Medicine.
The HIV Academy is pleased to be able to provide ASHM points for viewing Series One of HIV Academy. Your participation in watching two episodes will accrue one ASHM point. You will need to claim your HIV CPD Points via the ASHM Prescriber Online Portal, using your MyASHM login: http://prescriberportal.ashm.org.au